Patents Assigned to NEUROSENSE THERAPEUTICS LTD.
  • COMPOSITIONS COMPRISING CIPROFLOXACIN AND CELECOXIB
    Publication number: 20230120880
    Abstract: Embodiments relate to a tablet comprising celecoxib and ciprofloxacin or a pharmaceutically acceptable salt thereof, and low viscosity hydroxypropyl methylcellulose having a viscosity of less than 150 cP, when measured as a 2% solution in water at 20° C.
    Type: Application
    Filed: October 18, 2022
    Publication date: April 20, 2023
    Applicant: Neurosense Therapeutics Ltd.
    Inventors: Alon Ben Noon, Jeffrey Sterling, Oron Yacoby-Zeevi, Sharon Cohen Vered
  • Methods and compositions of anti-inflammatory drug and dicer activator for treatment of neuronal diseases
    Patent number: 10980780
    Abstract: The present invention discloses compositions, means and kits thereof for treating neuronal clinical indications in a mammalian subject. The composition comprises, inter alia, a synergistic combination of an anti-inflammatory drug and a DICER activator. The present invention further discloses methods for treating neuronal diseases including Motor neuron diseases (MNDs), ALS, FTD (Frontotemporal Dementia), macular degeneration (AMD) autism, and neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: April 20, 2021
    Assignee: NEUROSENSE THERAPEUTICS LTD.
    Inventor: Alon Ben-Noon